STOCKS NEWS UK SMALL-Antisoma rises after cancer drug update

STOCKS NEWS Reuters

Results diary

Europe [STXNEWS/EU] Real-time Equity News [E] [GB/EQUITY]

UK [STXNEWS/UK] Stocks on the move [HOT-RTRS]

UK smallcaps [STX/UKSC]

08:42GMT 15May2009-Antisoma rises after cancer drug update

----------------------------------------------------------

Shares in cancer specialist Antisoma (ASM.L) rise as much as 3 percent to 31 pence after the company releases fresh data for its leukaemia drug AS1411 in the run up to the American Society of Clinical Oncology annual meeting at the end of May.

"We believe AS1411 continues to show encouraging safety and efficacy in relapsed/refractory acute myeloid leukaemia," say analysts at Piper Jaffray in a note to clients.

The broker has a "buy" recommendation on the stock and a target price of 81 pence.

Reuters messaging rm://ben.deighton.thomsonreuters.com@reuters.net

08:24GMT 15May2009-Renishaw up; sees lower H2 operating loss

------------------------------------------------------------ Shares in Renishaw (RSW.L) gain 5 percent as the precision engineer says cost-cutting efforts mean second-half operating losses will be lower than the previously expected 10 million pounds.

KBC Peel Hunt upgrades the company to "Hold" from "Sell" and says it expects to increase 2009 forecasts.

"While we do not view Renishaw as being 'out of the woods' "While we do not view Renishaw as being 'out of the woods' it has made good inroads on cost cutting and net cash of 14 million pounds reduces the risk of the final dividend being passed," write the analysts in a note.